Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis. | Neurology;81(3): 206-10, 2013 Jul 16. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.

Kremer, Stéphane; Lamy, Julien; Magnus, Antoine; Oesterle, Hélène; Jeantroux, Jeremy; Trunet, Stéphanie; Armspach, Jean-Paul; Dietemann, Jean-Louis; de Sèze, Jérôme.

Affiliation

Kremer S; Service de Radiologie, Hôpital de Hautepierre, CHU de Strasbourg, Strasbourg, France. stephane.kremer@chrustrasbourg.fr

Neurology ; 81(3): 206-10, 2013 Jul 16.

Article in En | MEDLINE | ID: mdl-23761623

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Image Enhancement / Contrast Media / Gadolinium / Heterocyclic Compounds / Multiple Sclerosis Type of study: Evaluation_studies Limits: Adult / Female / Humans / Male Language: En Journal: Neurology Year: 2013 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Image Enhancement / Contrast Media / Gadolinium / Heterocyclic Compounds / Multiple Sclerosis Type of study: Evaluation_studies Limits: Adult / Female / Humans / Male Language: En Journal: Neurology Year: 2013 Document type: Article Affiliation country: